Tapewire

Nasdaq · USD

REGN

REGENERON PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
2010
SEC CIK
0000872589
Parsed reports
687

Last 12 months

Inside the activity.

0 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202601
Feb 2026035
Mar 2026013
Apr 202609
May 2026012
Jun 202600
Jul 202601
Aug 202602
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2023 Filed Jan 5, 2023 21:37 UTC SaleCommon Stock 14 $721.48 $10,100.72
Disclosure

SEC source: 0001883850-23-000023 · edgardoc.xml · nonDerivative · entry 1

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,268

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 14 shares of Company stock on January 3, 2023 at prices ranging from $721.09 to $721.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:22 UTC
McCourt MarionEVP Commercial
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,100 $0.00 Strike: $372.46 $0.00
Disclosure

SEC source: 0001883850-23-000021 · edgardoc.xml · derivative · entry 4

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,750

Underlying: Common Stock · 1,100 shares

Expires 2029-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:22 UTC
McCourt MarionEVP Commercial
SaleCommon Stock 1,100 $721.86 $794,046.00
Disclosure

SEC source: 0001883850-23-000021 · edgardoc.xml · nonDerivative · entry 2

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,079

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:22 UTC
McCourt MarionEVP Commercial
Exercise / conversionCommon Stock 1,100 $372.46 $409,706.00
Disclosure

SEC source: 0001883850-23-000021 · edgardoc.xml · nonDerivative · entry 1

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,179

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:21 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000020 · edgardoc.xml · derivative · entry 2

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:21 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000020 · edgardoc.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,247

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:21 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000018 · edgardoc.xml · derivative · entry 2

GOLDSTEIN JOSEPH L · CIK 0001225474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:21 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000018 · edgardoc.xml · nonDerivative · entry 1

GOLDSTEIN JOSEPH L · CIK 0001225474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,247

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:21 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000019 · edgardoc.xml · derivative · entry 4

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F3 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:21 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000019 · edgardoc.xml · nonDerivative · entry 1

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,247

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:20 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000017 · edgardoc.xml · derivative · entry 2

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:20 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000017 · edgardoc.xml · nonDerivative · entry 1

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,037

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:19 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000016 · edgardoc.xml · derivative · entry 5

SING GEORGE L · CIK 0001225471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:19 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000016 · edgardoc.xml · nonDerivative · entry 1

SING GEORGE L · CIK 0001225471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,214

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:16 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000015 · edgardoc.xml · derivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:16 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000015 · edgardoc.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,434

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:16 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000014 · edgardoc.xml · derivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:16 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000014 · edgardoc.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,434

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:15 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000013 · edgardoc.xml · derivative · entry 2

Zoghbi Huda Y · CIK 0001681643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:15 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000013 · edgardoc.xml · nonDerivative · entry 1

Zoghbi Huda Y · CIK 0001681643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,247

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:15 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,929 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000012 · edgardoc.xml · derivative · entry 2

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Common Stock · 1,929 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:15 UTC GrantCommon Stock 165 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000012 · edgardoc.xml · nonDerivative · entry 1

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,258

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:14 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 477 $0.00 Strike: $725.89 $0.00
Disclosure

SEC source: 0001883850-23-000011 · edgardoc.xml · derivative · entry 2

Thompson Craig B. · CIK 0001423419 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 477

Underlying: Common Stock · 477 shares

Expires 2033-01-03

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:14 UTC GrantCommon Stock 40 $0.00 $0.00
Disclosure

SEC source: 0001883850-23-000011 · edgardoc.xml · nonDerivative · entry 1

Thompson Craig B. · CIK 0001423419 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,613 $0.00 Strike: $482.68 $0.00
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · derivative · entry 12

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,613 shares

Expires 2031-01-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F7 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,145 $0.00 Strike: $374.12 $0.00
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · derivative · entry 11

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,145 shares

Expires 2030-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F7 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC SaleCommon Stock 311 $716.08 $222,700.88
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 10

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,093

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F6 · price: Represents volume-weighted average price of sales of 311 shares of Company stock on December 28, 2022 at prices ranging from $716.02 to $716.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC SaleCommon Stock 2,266 $715.48 $1,621,277.68
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 9

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,404

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F5 · price: Represents volume-weighted average price of sales of 2,266 shares of Company stock on December 28, 2022 at prices ranging from $715.04 to $715.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC SaleCommon Stock 1,022 $714.61 $730,331.42
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 8

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,670

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F4 · price: Represents volume-weighted average price of sales of 1,022 shares of Company stock on December 28, 2022 at prices ranging from $714.00 to $714.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC SaleCommon Stock 1,198 $713.66 $854,964.68
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 7

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,692

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3 · price: Represents volume-weighted average price of sales of 1,198 shares of Company stock on December 28, 2022 at prices ranging from $713.17 to $713.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC SaleCommon Stock 100 $711.95 $71,195.00
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 6

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,890

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC SaleCommon Stock 679 $710.63 $482,517.77
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 5

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,990

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2 · price: Represents volume-weighted average price of sales of 679 shares of Company stock on December 28, 2022 at prices ranging from $710.48 to $710.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC SaleCommon Stock 1 $709.92 $709.92
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 4

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,669

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC SaleCommon Stock 181 $707.87 $128,124.47
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 3

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,670

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC Exercise / conversionCommon Stock 3,613 $482.68 $1,743,922.84
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 2

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 28, 2022 Filed Dec 30, 2022 21:10 UTC Exercise / conversionCommon Stock 2,145 $374.12 $802,487.40
Disclosure

SEC source: 0001883850-22-000143 · edgardoc.xml · nonDerivative · entry 1

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,238

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

Read SEC document
December 20, 2022 Filed Dec 21, 2022 22:45 UTC OtherCommon Stock 111 $729.71 $80,997.81
Disclosure

SEC source: 0001883850-22-000141 · edgardoc.xml · nonDerivative · entry 2

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 1,961

F2 · price: Represents volume-weighted average price of sales of 111 shares of Company stock on December 20, 2022 at prices ranging from $729.44 to $729.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2022 at each separate price.

Read SEC document
December 20, 2022 Filed Dec 21, 2022 22:45 UTC OtherCommon Stock 30 $728.86 $21,865.80
Disclosure

SEC source: 0001883850-22-000141 · edgardoc.xml · nonDerivative · entry 1

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 2,072

F1 · price: Represents volume-weighted average price of sales of 30 shares of Company stock on December 20, 2022 at prices ranging from $728.81 to $728.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2022 at each separate price.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 22:44 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 16,254 $0.00 Strike: $726.53 $0.00
Disclosure

SEC source: 0001883850-22-000139 · edgardoc.xml · derivative · entry 6

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,254

Underlying: Common Stock · 16,254 shares

Expires 2032-12-16

F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 22:44 UTC GrantCommon Stock 1,651 $0.00 $0.00
Disclosure

SEC source: 0001883850-22-000139 · edgardoc.xml · nonDerivative · entry 1

VAGELOS P ROY · CIK 0001013064 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,083

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:09 UTC
Van Plew Daniel PEVP & General Mgr, Industrial
GrantNon-Qualified Stock Option (right to buy) · Derivative 14,019 $0.00 Strike: $726.53 $0.00
Disclosure

SEC source: 0001883850-22-000137 · edgardoc.xml · derivative · entry 3

Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr, Industrial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,019

Underlying: Common Stock · 14,019 shares

Expires 2032-12-16

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:09 UTC
Van Plew Daniel PEVP & General Mgr, Industrial
GrantCommon Stock 3,798 $0.00 $0.00
Disclosure

SEC source: 0001883850-22-000137 · edgardoc.xml · nonDerivative · entry 1

Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr, Industrial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,884

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:08 UTC
STAHL NEILEVP Research and Development
GrantNon-Qualified Stock Option (right to buy) · Derivative 4,063 $0.00 Strike: $726.53 $0.00
Disclosure

SEC source: 0001883850-22-000136 · edgardoc.xml · derivative · entry 4

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,063

Underlying: Common Stock · 4,063 shares

Expires 2032-12-16

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:08 UTC
STAHL NEILEVP Research and Development
GrantCommon Stock 1,101 $0.00 $0.00
Disclosure

SEC source: 0001883850-22-000136 · edgardoc.xml · nonDerivative · entry 1

STAHL NEIL · CIK 0001226689 · EVP Research and Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,100

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:08 UTC
MURPHY ANDREW JEVP Research
GrantNon-Qualified Stock Option (right to buy) · Derivative 15,238 $0.00 Strike: $726.53 $0.00
Disclosure

SEC source: 0001883850-22-000135 · edgardoc.xml · derivative · entry 3

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,238

Underlying: Common Stock · 15,238 shares

Expires 2032-12-16

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:08 UTC
MURPHY ANDREW JEVP Research
GrantCommon Stock 4,129 $0.00 $0.00
Disclosure

SEC source: 0001883850-22-000135 · edgardoc.xml · nonDerivative · entry 1

MURPHY ANDREW J · CIK 0001796226 · EVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,747

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:07 UTC
McCourt MarionEVP Commercial
GrantNon-Qualified Stock Option (right to buy) · Derivative 10,971 $0.00 Strike: $726.53 $0.00
Disclosure

SEC source: 0001883850-22-000134 · edgardoc.xml · derivative · entry 3

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,971

Underlying: Common Stock · 10,971 shares

Expires 2032-12-16

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:07 UTC
McCourt MarionEVP Commercial
GrantCommon Stock 2,973 $0.00 $0.00
Disclosure

SEC source: 0001883850-22-000134 · edgardoc.xml · nonDerivative · entry 1

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,079

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:07 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
GrantNon-Qualified Stock Option (right to buy) · Derivative 10,159 $0.00 Strike: $726.53 $0.00
Disclosure

SEC source: 0001883850-22-000133 · edgardoc.xml · derivative · entry 5

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,159

Underlying: Common Stock · 10,159 shares

Expires 2032-12-16

F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:07 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
GrantCommon Stock 2,752 $0.00 $0.00
Disclosure

SEC source: 0001883850-22-000133 · edgardoc.xml · nonDerivative · entry 1

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,110

F1 · kind: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 16, 2024 and 50% on December 16, 2026.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.